Cosméticos com presença de disruptores endócrinos e gestação: percepção de risco pelos profissionais de saúde
DOI:
https://doi.org/10.15253/2175-6783.20242593619Palavras-chave:
Gravidez; Cosméticos; Disruptores Endócrinos; Pessoal de Saúde.Resumo
Objetivo: conhecer a percepção dos profissionais de saúde da Atenção Primária à Saúde quanto aos riscos associados ao uso de cosméticos que contêm disruptores endócrinos durante a gestação. Métodos: trata-se de um estudo qualitativo. Os participantes foram 17 profissionais de saúde que fazem consultas às gestantes na Atenção Primária à Saúde. A coleta de dados ocorreu por meio de entrevista semiestruturada. Para a análise das entrevistas, contou-se com a Análise de Conteúdo, e com referenciais teóricos de pesquisadores da área. Resultados: observou-se que há pouco conhecimento da maioria dos participantes sobre o conceito de disruptores endócrinos, os quais relataram pouca segurança para recomendarem, ou não, sobre o uso de cosméticos e produtos de higiene pessoal e, ainda, poucos demonstraram conhecer os riscos que possam apresentar à saúde. Conclusão: os profissionais de saúde mostraram que há uma fragilidade quanto ao seu conhecimento sobre os riscos dos disruptores endócrinos presentes nos cosméticos, e, consequentemente, encontram dificuldades para orientar as gestantes a reduzirem as exposições prejudiciais. Contribuições para a prática: sensibilização dos profissionais para a necessidade constante de atualizações para prestarem aconselhamento com segurança às gestantes.
Referências
Gómez-Roig MD, Pascal R, Cahuana MJ, García-Algar O, Sebastiani G, Andreu-Fernández V, et al. Environmental exposure during pregnancy: influence on prenatal development and early life: a comprehensive review. Fetal Diagn Ther. 2021;48(4):245-57. doi: https://doi.org/10.1159/000514884
Tabares GG, Mordecay VC. Disruptores endócrinos em reproducción. Rev Colomb Menopausa [Internet]. 2020 [cited Apr 23, 2024];26(1):7-19. Available from: https://docs.bvsalud.org/biblioref/2021/05/1224400/disruptores-endocrinos.pdf
Puche-Juarez M, Toledano JM, Moreno-Fernandez J, Gálvez-Ontiveros Y, Rivas A, Diaz-Castro J, et al. The role of endocrine disrupting chemicals in gestation and pregnancy outcomes. Nutrients. 2023;15(21):4657. doi: https://doi.org/10.3390/nu15214657
Li H, Zheng J, Wang H, Huang G, Huang Q, Feng N, et al. Maternal cosmetics use during pregnancy and risks of adverse outcomes: a prospective cohort study. Sci Rep. 2019;9(1):8030. https://doi.org/10.1038/s41598-019-44546-z
Green MP, Harvey AJ, Finger BJ, Tarulli GA. Endocrine disrupting chemicals: Impacts on human fertility and fecundity during the peri-conception period. Environ Res. 2021;194:110694. doi: https://doi.org/10.1016/j.envres.2020.110694
Pinheiro AC, Queirós C, Alvim AS. Manifestações dermatológicas na gravidez. Acta Med Port. 2022; 35(5):376-83. doi: https://dx.doi.org/10.20344/amp.13520
Philippat C, Rolland M, Lyon-Caen S, Pin I, Sakhi AK, Sabaredzovic A, et al. Pre- and early post-natal exposure to phthalates and DINCH in a new type of mother-child cohort relying on within-subject pools of repeated urine samples. Environ Pollut. 2021;287:117650. doi: http://dx.doi.org/10.1016/j.envpol.2021.117650
Marguillier E, Beranger R, Garlantezec R, Levêque J, Lassel L, Rousseau C, et al. Endocrine disruptors and pregnancy: Knowledge, attitudes and practice of perinatal health professionals. A French multicentre survey. Eur J Obstet Gynecol Reprod Biol. 2020;252:233-8. doi: https://doi.org/10.1016/j.ejogrb.2020.06.032
Albouy M, Parthenay M, Nogues M, Leyris A, Degorce L, Barthelemy Z, et al. A clinical preventive strategy based on a digital tool to improve access to endocrine disruptors exposure prevention: the MEDPREVED study. Int J Environ Res Public Health. 2022;19(19):11993. doi: https://doi.org/10.3390/ijerph191911993
Ouazzani HE, Rouillon S, Venisse N, Sifer-Rivière L, Dupuis A, Cambien G, et al. Impact of perinatal environmental health education intervention on exposure to endocrine disruptors during pregnancy — PREVED study: study protocol for a randomized controlled trial. Trials. 2021; 22(1):876. doi: https://doi.org/10.1186/s13063-021-05813-5
Park S, Chung C. How do mothers with young children perceive endocrine-disrupting chemicals?: an exploratory qualitative study. Korean J Women Health Nurs. 2023;29(4):337-47. doi: https://dx.doi.org/10.4069/kjwhn.2023.11.28
Ministério da Saúde (BR). e-Gestor Atenção Básica. Informação e Gestão da Atenção Básica [Internet]. 2020 [cited July 13, 2024]. Available from: https://egestorab.saude.gov.br/paginas/acessoPublico/relatorios/relHistoricoCoberturaAB.xhtml
Bardin L. Análise de conteúdo. São Paulo: Edições 70; 2016.
Marie C, Garlantézec R, Béranger R, Ficheux AS. Use of cosmetic products in pregnant and breastfeeding women and young children: Guidelines for interventions during the perinatal period from the French National College of Midwives. J Midwifery Womens Health. 2022;67(Suppl 1):99-112. doi: https://dx.doi.org/10.1111/jmwh.13428
Yang Z, Zhang J, Wang M, Wang X, Liu H, Zhang F, et al. Prenatal endocrine-disrupting chemicals exposure and impact on offspring neurodevelopment: a systematic review and meta-analysis. Neurotoxicology. 2024;103:335-57. doi: https://doi.org/10.1016/j.neuro.2024.07.006
Kirtana A, Seetharaman B. Comprehending the role of endocrine disruptors in inducing epigenetic toxicity. Endocr Metab Immune Disord Drug Targets. 2022;22(11):1059-72. https://doi.org/10.2174/1871530322666220411082656
Predieri B, Iughetti L, Bernasconi S, Street ME. Endocrine disrupting chemicals’ effects in children: what we know and what we need to learn? Int J Mol Sci. 2022;23(19):11899. doi: https://doi.org/10.3390/ijms231911899
Kiess W, Häussler G, Vogel M. Endocrine-disrupting chemicals and child health. Best Pract Res Clin Endocrinol Metab. 2021;35(5):101516. doi: https://doi.org/10.1016/j.beem.2021.101516
Derakhshan A, Shu H, Broeren MAC, Kortenkamp A, Lindh CH, Demeneix B, et al. Association of endocrine disrupting chemicals exposure with human chorionic gonadotropin concentrations in pregnancy. Environ Int. 2023;178:108091. doi: https://doi.org/10.1016/j.envint.2023.108091
Preston EV, Fruh V, Quinn MR, Hacker MR, Wylie BJ, O’Brien K, et al. Endocrine disrupting chemical-associated hair product use during pregnancy and gestational age at delivery: a pilot study. Environ Health. 2021;20(1):86. doi: https://doi.org/10.1186/s12940-021-00772-5
Liu B, Zhu X, Zhang Y, Yan J, Ren A, Su Y, et al. Influence of maternal endocrine disrupting chemicals exposure on adverse pregnancy outcomes: a systematic review and meta-analysis. Ecotoxicol Environ Saf. 2024;270:115851. doi: https://dx.doi.org/10.1016/j.ecoenv.2023.115851
Gore AC, Crews D, Doan LL, Merril ML, Patisaul H, Zota A. Introdução aos disruptores endócrinos (DEs) um guia para governos e organizações de interesse público [Internet]. 2014 [cited Apr 13, 2024]. Available from: https://www.endocrino.org.br/media/uploads/PDFs/ipen-intro-edc-v1_9h-pt-print.pdf
Rolfo A, Nuzzo AM, Amicis R, Moretti L, Bertoli S, Leone A. Fetal-maternal exposure to endocrine disruptors: correlation with diet intake and pregnancy outcomes. Nutrients. 2020;12(6):1744. doi: https://doi.org/10.3390/nu12061744
Asori M, Omololu F, Ande A, Babatunde E, Adewale O, Akande O. Impacts of endocrine disruptors on reproductive health in the era of increased personal care and beauty products usage. Bull Natl Res Cent. 2022;46(1):61. doi: https://dx.doi.org/10.1186/s42269-022-00826-w
Marinello WP, Patisaul HB. Endocrine disrupting chemicals (EDCs) and placental function: impact on fetal brain development. Adv Pharmacol. 2021;92:347-400. doi: https://doi.org/10.1016/bs.apha.2021.04.003
Lin HW, Feng HX, Chen L, Yuan XJ, Tan Z. Maternal exposure to environmental endocrine disruptors during pregnancy is associated with pediatric germ cell tumors. Nagoya J Med Sci. 2020;82(2):323-33. doi: https://doi.org/10.18999/nagjms.82.2.315
Arruda HFBR, Silva LS. Esthetic skin care with the use of dermocosmetics and cosmetics during pregnancy. Braz J Develop. 2022;8(12):77348-69. doi: https://dx.doi.org/10.34117/bjdv8n12-040
Gomes FS, Paula TAP, Souza VP, Araújo CM, Ferreira BES. Os impactos dos desreguladores endócrinos sobre a puberdade precoce: revisão integrativa. Rev Eletr Evid Enferm. 2021;7(1):12-25. doi: http://dx.doi.org/10.26544/Reeev7n12021-12-25
Haggerty DK, Upson K, Pacyga DC, Franko JE, Braun JM, Strakovsky RS. Reproductive toxicology: pregnancy exposure to endocrine disrupting chemicals: implications for women’s health. Reproduction. 2021;162(5):169-80. doi: http://dx.doi.org/10.1530/REP-21-0051
Banker M, Puttabyatappa M, O’Day P, Goodrich JM, Kelley AS, Domino SE, et al. Association of maternal-neonatal steroids with early pregnancy endocrine disrupting chemicals and pregnancy outcomes. J Clin Endocrinol Metab. 2021;106(3):665-87. doi: https://doi.org/10.1210/clinem/dgaa909
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2024 Rev Rene

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.